PTK2B and neoplasm: Moreover, PF-562271 not only inhibited Pyk2 signaling in tumor cells but also reduced TAM infiltration in recurrent tumors [24], suggesting a dual mechanism of action: direct inhibition of tumor cell signaling and disruption of TAM-mediated Pyk2 activation.